» Articles » PMID: 34060546

Commercially Available Rapid Diagnostic Tests for the Detection of High Priority Pathogens: Status and Challenges

Overview
Journal Analyst
Specialty Chemistry
Date 2021 Jun 1
PMID 34060546
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The ongoing COVID-19 pandemic has shown the importance of having analytical devices that allow a simple, fast, and robust detection of pathogens which cause epidemics and pandemics. The information these devices can collect is crucial for health authorities to make effective decisions to contain the disease's advance. The World Health Organization published a list of primary pathogens that have raised concern as potential causes of future pandemics. Unfortunately, there are no rapid diagnostic tests commercially available and approved by the regulatory bodies to detect most of the pathogens listed by the WHO. This report describes these pathogens, the available detection methods, and highlights areas where more attention is needed to produce rapid diagnostic tests for future pandemic surveillance.

Citing Articles

Evolving Landscape of Emerging Virus Diagnosis: Challenges and Innovations.

Kumar A, Saini S, Anvikar A, Mishra N, Misra G Mol Biotechnol. 2025; .

PMID: 40042766 DOI: 10.1007/s12033-025-01385-w.


Mismatch of Supply and Demand: Marburg Virus Disease Outbreaks Need Countermeasures But Will Not Provide Opportunity for Clinical Trials.

Sprecher A, Van Herp M Methods Mol Biol. 2024; 2877:3-24.

PMID: 39585610 DOI: 10.1007/978-1-0716-4256-6_1.


Leishmania tarentolae as a platform for the production of vaccines against viral pathogens.

Zimna M, Krol E NPJ Vaccines. 2024; 9(1):212.

PMID: 39505865 PMC: 11541885. DOI: 10.1038/s41541-024-01005-9.


Gold Nanotapes and Nanopinecones in a Quantitative Lateral Flow Assay for the Cancer Biomarker Carcinoembryonic Antigen.

Fox J, Batchelor D, Roberts H, Moorcroft S, Valleley E, Coletta P ACS Appl Nano Mater. 2023; 6(19):17769-17777.

PMID: 37854850 PMC: 10580237. DOI: 10.1021/acsanm.3c03053.


A Comparison Study of the Detection Limit of Omicron SARS-CoV-2 Nucleocapsid by Various Rapid Antigen Tests.

Dobrynin D, Polischuk I, Pokroy B Biosensors (Basel). 2022; 12(12).

PMID: 36551050 PMC: 9775131. DOI: 10.3390/bios12121083.